5,039 results on '"Esophageal Fistula"'
Search Results
2. Primary Posterior Tracheopexy Prevents Tracheal Collapse (PORTRAIT)
- Author
-
For Wis(h)dom Foundation, Erasmus Medical Center, Great Ormond Street Hospital for Children NHS Foundation Trust, Karolinska University Hospital, and Maud Lindeboom, Principal investigator
- Published
- 2024
3. A case of refractory chylothorax due to an unenclosed esophageal hiatus after subtotal esophagectomy treated with lipiodol lymphangiography.
- Author
-
Kaneda, Koji, Miwa, Takeshi, Okumura, Tomoyuki, Numata, Yoshihisa, Fukasawa, Mina, Watanabe, Toru, Hashimoto, Isaya, Naruto, Norihito, and Fujii, Tsutomu
- Subjects
ESOPHAGEAL fistula ,THORACIC duct ,PATIENT positioning ,CHEST (Anatomy) ,CHYLOTHORAX ,LYMPHANGIOGRAPHY - Abstract
Background: Chylothorax, a rare but serious complication following esophagectomy, can lead to dehydration, malnutrition, and even mortality. Surgical intervention is considered when conservative treatment is ineffective; however, in some refractory cases, the cause of chylothorax remains unclear. We report a case of refractory chylothorax caused by abdominal chyle leakage into the pleural space via an unenclosed esophageal hiatus. Case presentation: A 66-year-old man was diagnosed with advanced esophageal squamous cell carcinoma. The patient underwent robot-assisted thoracoscopic subtotal esophagectomy in the prone position with retrosternal gastric tube reconstruction following neoadjuvant chemotherapy. The thoracic duct was ligated and resected because of tumor invasion. Chylothorax and chylous ascites were observed 2 weeks after surgery but did not improve despite conservative management with medications and drainage. Lymphoscintigraphy through the inguinal lymph node showed tracer accumulation in the fluid in both the abdominal and pleural spaces. Lipiodol lymphangiography revealed abdominal lymphoid leakage, but no leakage was detected from the thoracic duct or mediastinum. We considered that the chylothorax was caused by chylous ascites flowing into the pleural space via an unenclosed esophageal hiatus, and we performed surgical intervention. Laparotomy revealed abdominal chyle leakage and a fistula at the esophageal hiatus with the inflow of ascites into the thoracic cavity. Lipiodol lymphangiography was additionally performed for treating abdominal lymphorrhea after surgery, and resulted in the improvement of the chylothorax and ascites. The patient was discharged with no recurrence of chylothorax or chylous ascites. Conclusions: Refractory chylothorax can occur due to chylous ascites flowing into the pleural space via an unenclosed esophageal hiatus. When the site of chylothorax leakage is unclear, the possibility of inflowing chylous ascites via the unenclosed esophageal hiatus should be explored. Esophageal hiatus closure and lipiodol lymphangiography could be effective in treating refractory chylothorax of unknown cause after esophagectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Aortoesophageal fistula with hemorrhagic shock successfully treated with resuscitative endovascular balloon occlusion of the aorta.
- Author
-
Hirai, Tadayuki, Okajima, Masaki, Noda, Toru, and Goto, Yoshikazu
- Subjects
- *
ESOPHAGEAL surgery , *FISTULA , *HEMATEMESIS , *AORTIC diseases , *BLOOD vessels , *COMPUTED tomography , *THORACIC surgery , *ESOPHAGEAL fistula , *TREATMENT effectiveness , *ESOPHAGEAL tumors , *ENDOVASCULAR surgery , *BALLOON occlusion , *HEMORRHAGIC shock , *PLASTIC surgery , *HEMOSTASIS , *DISEASE complications - Abstract
Background: Aortoesophageal fistula (AEF) is a rare cause of upper gastrointestinal hemorrhage. Despite diagnostic and therapeutic advances, the mortality rate in AEF patients remains high because of its fulminant course, even with maximal intensive care. Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a resuscitation technique to control life-threatening bleeding. It has become an important modality in the management of life-threatening, traumatic or non-traumatic, arterial bleeding. However, it's use in hemorrhagic shock caused by cancer has rarely been reported. Case presentation: A 51-year-old woman with a history of esophageal cancer presented to our emergency department with hematemesis. Computed tomography was performed because of a strong suspicion of hemorrhagic shock. With a diagnosis of AEF due to esophageal cancer, emergency thoracic endovascular aortic repair was performed while the bleeding was controlled using REBOA. Staged elective esophageal reconstruction was successfully performed. Conclusions: Hemostasis is crucial in patients who present with suspected hemorrhagic shock attributable to AEF. The timely implementation of REBOA has shown promise and potential effectiveness in such cases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. A Comprehensive Analysis of Reported Adverse Events and Device Failures Associated with Esophageal Self-Expandable Metal Stents: An FDA MAUDE Database Study.
- Author
-
Jaber, Fouad, Alsakarneh, Saqr, Alsharaeh, Tala, Salahat, Ahmed-Jordan, Jaber, Mohammad, Mohamed, Islam, Gangwani, Manesh Kumar, Aldiabat, Mohammad, Kilani, Yassine, Ahmed, Mohamed, Madi, Mahmoud, Numan, Laith, and Bazarbashi, Ahmad Najdat
- Subjects
- *
ESOPHAGEAL fistula , *DATABASES , *DEGLUTITION disorders , *MANUFACTURING industries , *STATISTICS - Abstract
Introduction: Esophageal Stents are used to maintain esophageal lumen patency in esophageal strictures caused by intrinsic and/or extrinsic malignancies and the occlusion of concomitant esophageal fistulas. While data on the efficacy and safety of esophageal stents exist, comprehensive evaluation of adverse events is limited. The aim of this study is to investigate the reported adverse events and device failures associated with esophageal self-expandable metal stents (SEMS) using the FDA's Manufacturer and User Facility Device Experience (MAUDE) database. Methods: Post-marketing surveillance data for the esophageal SEMSs were analyzed using the FDA's MAUDE database from January 2014 to December 10, 2023. The outcomes of interest were patient-related adverse events and device failures. Statistical analysis was performed using Microsoft Excel 2010 and SPSS. Pooled numbers and percentages were calculated for each adverse event. Continuous variables underwent analysis using a two-tailed student t test, and significance was set to p ≤ 0.05. Results: During the study period, 548 MAUDE reports revealed 873 device failures and 186 patient-related adverse events. The most common device issues were stent activation, positioning, or separation problems (4 n = 403; 46.2%), followed by device detachment or migration (n = 109, 12.5%), and material problems (n = 93, 10.7%). Patient complications included dysphagia/odynophagia (10%), perforation, pain, and bleeding (each 7.6%). The most common device failures in over-the-wire (OTW) stents and through-the-scope (TTS) stents were activation, positioning, or separation problems (TTS: n = 183, 52.6% vs OTW: n = 220, 41.9%). Compared to OTW stents, TTS stents had higher migration and breakage (13.5% vs. 11.8%, p = 0.24), and (9.2% vs. 6.7%, p = 0.08) respectively, while OTW stents had more challenges with stent advancement or removal (5.1% vs. 0.3%, p < 0.001 and 4.6% vs 3.4%, p = 0.19, respectively) and material problems (14.7% vs. 4.6%, p < 0.001). Activation, positioning, and separation problems were the most frequent device failures in fully covered (FC) and partially covered (PC) stents (FC: n = 62, 32.8%, PC: n = 168, 43.5%). FC stents had higher migration rates (20.6% vs 9.8%, p < 0.001), while PC stents exhibited more material problems (17.4% vs. 5.8%, p < 0.001) and difficulties with advancing the stents (6.7% vs. 0%, p < 0.001). Conclusion: Our examination showed a prevalence of reported device complications associated with stent activation, positioning, and separation problems. Dysphagia or odynophagia emerged as the most frequently reported patient complication. Furthermore, our analysis, provides insights into TTS vs. OTW and FC vs. PC esophageal SEMSs, enabling endoscopists and manufacturers to better understand adverse events and potentially optimize device design for future iterations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Prognostic factors for esophageal respiratory fistula in unresectable esophageal squamous cell carcinoma treated with radiotherapy.
- Author
-
Qi, Jia-Chao, Zhi, Lijia, Li, Huangyu, Huang, Yanping, Ye, Yuming, Li, Hao, Wang, Tiezhu, Lin, Li, and Zhuang, Yuezhen
- Subjects
- *
ESOPHAGEAL fistula , *SQUAMOUS cell carcinoma , *PROPORTIONAL hazards models , *PROGNOSIS , *PLATELET lymphocyte ratio , *NEUTROPHIL lymphocyte ratio - Abstract
Limited studies have focused on the prognostic factors of esophageal respiratory fistula (ERF) associated with radiotherapy in patients with unresectable esophageal squamous cell carcinoma (ESCC). Between January 1st, 2014 and January 1st, 2021, we included patients who were initially diagnosed with unresectable ESCC and underwent radiotherapy. All patients were followed up for a period of 2 years after completing their radiotherapy treatment. The primary outcomes of the study were defined as death or severe adverse events. The survival curves of ERF were calculated using the Kaplan–Meier method. Cox proportional hazards model was employed to calculated the prognostic factors. A cohort of 232 patients underwent radiotherapy, of whom 32 patients experienced ERF. The median period from initial diagnosis of ESCC to ERF was 5.75 months, and the median period from ERF to the primary outcome was 4.6 weeks. Neck + upper chest location (odds ratio [OR] 3.305), high T stage (OR 1.765), esophageal stenosis (OR 1.073), high neutrophil to lymphocyte ratio (NLR) (OR 1.384) and platelet to lymphocyte ratio (PLR) (OR 1.765) were risk factors for the occurrence of ERF. Cox regression analysis suggested that tumor location (hazards ratio [HR] 3.572, 95% confidence interval [CI] 2.467–5.1), high T stage (HR 4.050, 95% CI 2.812–5.831), esophageal stenosis (HR 2.643, 95% CI 1.753–3.983), high PLR (HR 2.541, 95% CI 1.868–3.177) were independent prognostic factors for poor survival. Esophageal stenosis, neck + upper chest tumor location, high T stage and PLR predicted the prognosis of ERF in ESCC patients undergoing radiotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy.
- Author
-
Kong, Yue, Su, Miaoyi, Fang, Jun, Chen, Mengyuan, Zheng, Chao, Jiang, Youhua, Tao, Kaiyi, Wang, Changchun, Qiu, Guoqin, Ji, Yongling, Wang, Yuezhen, and Yang, Yang
- Subjects
- *
PACLITAXEL , *SQUAMOUS cell carcinoma , *ESOPHAGEAL fistula , *RADIATION pneumonitis , *IMMUNOTHERAPY , *RADIOTHERAPY - Abstract
With the success of immunotherapy in advanced esophageal cancer, neoadjuvant chemo-immunotherapy (CIT) is being increasingly used for local staged esophageal cancer, especially in the context of clinical trials, which brings similar pCR with neoadjuvant chemoradiotherapy and shows promising results. However, there is still a part of potentially operable patients can't undergo surgery after neoadjuvant chemo-immunotherapy. The follow-up treatment and prognosis of this population remain unclear. Patients pathologically diagnosed with ESCC, clinical stage T1-3N+M0 or T3-4aNanyM0 (AJCC 8th), PS 0–1 were retrospectively enrolled from 1/2020 to 6/2021 in Zhejiang Cancer Hospital. All patients firstly received PD-1 inhibitors plus chemotherapy (albumin paclitaxel, 260 mg/m2 on day 1 plus carboplatin AUC = 5 on day 1) every 3 weeks for 2–4 cycles. For those patients who did not receive surgery, definitive radiotherapy with 50.4 Gy/28F or 50 Gy/25F was adopted using VMAT, concurrent with chemotherapy or alone. The concurrent chemotherapy regimens included weekly TC (paclitaxel 50 mg/m2, d1, carboplatin AUC = 2, d1) or S1 (60 mg bid d1–14, 29–42). The survival outcomes and treatment toxicity were recorded and analyzed. A total of 56 eligible patients were finally identified from 558 patients who were treated in department of thoracic surgery, among all the patients, 25 (44.6%) received radiotherapy alone, and 31 (55.4%) received chemoradiotherapy after neoadjuvant CIT. The median follow-up was 20.4 months (interquartile range [IQR] 8.7–27 months). The median PFS and OS were 17.9 months (95% confidence interval [CI] 11.0–21.9 months) and 20.5 months (95% CI 11.8–27.9 months), respectively. In the subgroup analysis, the median OS was 26.3 months (95% CI 15.33–NA) for patients exhibiting partial response (PR) to CIT, compared to 17 months (95% CI 8.77–26.4) for those with stable disease (SD) or progressive disease (PD), yielding a hazard ratio (HR) of 0.54 (95% CI 0.27–1.06, P = 0.07). No significant difference was observed for patients received radiotherapy alone or chemoradiotherapy with HR = 0.73 (95% CI 0.72–2.6, P = 0.33). The most common Adverse events (AEs) observed during this study were anemia (98.2%), leukopenia (83.9%), thrombocytopenia (53.6%). AEs of grade ≥ 3 radiation-induced pneumonitis and esophagitis were 12.5% and 32.1%, especially, 6 patients (10.7%) died from esophageal fistula and 2 patients (3.6%) died from grade 5 pneumonitis. For local advanced ESCC patients after neoadjuvant CIT who did not receive surgery, definitive radiotherapy was an optional treatment strategy. However, those patients with no response to CIT also showed poor response to radiotherapy, and particular attention should be paid to treatment related toxicity, especially esophageal fistula. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Treatment of lower cervical spine fracture with ankylosing spondylitis by simple long anterior cervical plate: a retrospective study of 17 cases.
- Author
-
Weifu Chen, Yu Yang, Wenjun Pan, Xinhuan Lei, Zhenghua Hong, and Hua Luo
- Subjects
VERTEBRAL fractures ,CERVICAL vertebrae ,ANKYLOSING spondylitis ,ESOPHAGEAL fistula ,AUTOIMMUNE diseases ,SPINAL nerves ,CLINICAL deterioration - Abstract
Objective: Ankylosing spondylitis (AS), an autoimmune disease, often leads to lower cervical spine fractures, with the potential for severe spinal nerve damage even from low-energy injuries. The optimal treatment approach remains debated. Methods: A retrospective study involved 17 AS patients with lower cervical spine fractures who received anterior cervical fixation. Most presented cervicothoracic or thoracolumbar kyphosis, with 11 exhibiting neurological deficits. Patient characteristics, clinical data, visual analog scale (VAS), complications, and nerve recovery were analyzed. Results: No postoperative neurological deterioration occurred. All cases experienced complete fusion of fractures during the follow-up period. Preoperative VAS significantly decreased at 3 days and 3 months post-surgery. Of the 11 patients with preoperative neurological deficits, approximately 54.5% showed improvement post-surgery. No complications were reported, such as esophageal fistula, wound infection, or fixation failure. Conclusion: Anterior internal fixation is a possible treatment for AS-related lower cervical fractures. This approach ensures satisfactory spinal stability and neurological recovery with proper cranial traction and external fixation post-surgery. Our findings demonstrate that this surgical method is safe and effective. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. The characteristics of eating, drinking and oro-pharyngeal swallowing difficulties associated with repaired oesophageal atresia/tracheo-oesophageal fistula: a systematic review and meta-proportional analysis.
- Author
-
Stewart, Alexandra, Govender, Roganie, Eaton, Simon, Smith, Christina H., De Coppi, Paolo, and Wray, Jo
- Subjects
- *
ESOPHAGEAL fistula , *DEGLUTITION , *INGESTION , *SCIENCE databases , *WEB databases - Abstract
Introduction: Eating, drinking and swallowing difficulties are commonly reported morbidities for individuals born with OA/TOF. This study aimed to determine the nature and prevalence of eating, drinking and oro-pharyngeal swallowing difficulties reported in this population. Method: A systematic review and meta-proportional analysis were conducted (PROSPERO: CRD42020207263). MEDLINE, EMBASE, CINAHL, Pubmed, Scopus, Web of Science databases and grey literature were searched. Quantitative and qualitative data were extracted relating to swallow impairment, use of mealtime adaptations and eating and drinking-related quality of life. Quantitative data were summarised using narrative and meta-proportional analysis methods. Qualitative data were synthesised using a meta-aggregation approach. Where quantitative and qualitative data described the same phenomenon, a convergent segregated approach was used to synthesise data. Results: Sixty-five studies were included. Six oro-pharyngeal swallow characteristics were identified, and pooled prevalence calculated: aspiration (24%), laryngeal penetration (6%), oral stage dysfunction (11%), pharyngeal residue (13%), nasal regurgitation (7%), delayed swallow initiation (31%). Four patient-reported eating/drinking difficulties were identified, and pooled prevalence calculated: difficulty swallowing solids (45%), difficulty swallowing liquids (6%), odynophagia (30%), coughing when eating (38%). Three patient-reported mealtime adaptations were identified, and pooled prevalence calculated: need for water when eating (49%), eating slowly (37%), modifying textures (28%). Mixed methods synthesis of psychosocial impacts identified 34% of parents experienced mealtime anxiety and 25% report challenging mealtime behaviours reflected in five qualitative themes: fear and trauma associated with eating and drinking, isolation and a lack of support, being aware and grateful, support to cope and loss. Conclusions: Eating and drinking difficulties are common in adults and children with repaired OA/TOF. Oro-pharyngeal swallowing difficulties may be more prevalent than previously reported. Eating, drinking and swallowing difficulties can impact on psychological well-being and quality of life, for the individual and parents/family members. Long-term, multi-disciplinary follow-up is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Cryoballoon-Assisted Pulmonary Vein Isolation and Left Atrial Roof Ablation Using a Simplified Sedation Strategy without Esophageal Temperature Monitoring: No Notable Thermal Esophageal Lesions and Low Arrhythmia Recurrence Rates after 2 Years.
- Author
-
Erkapic, Damir, Roussopoulos, Konstantinos, Aleksic, Marko, Sözener, Korkut, Kostev, Karel, Rosenbauer, Josef, Sossalla, Samuel, Gündüz, Dursun, Labenz, Joachim, Tanislav, Christian, and Weipert, Kay Felix
- Subjects
- *
PULMONARY veins , *ESOPHAGEAL fistula , *LEFT heart atrium , *ATRIAL fibrillation , *ARRHYTHMIA , *CRYOSURGERY - Abstract
Background: Atrial fibrillation (AF) ablation is increasingly effective for managing heart rhythm but poses risks like esophageal fistulas. Minimizing esophageal thermal lesions while simplifying procedures is crucial. Methods: This prospective study involved 100 consecutive AF patients undergoing cryoballoon ablation with simplified sedation, without esophageal temperature monitoring. Patients with paroxysmal AF (Group A) received pulmonary vein isolation only, while those with persistent AF (Group B) also had left atrial roof ablation. Gastroesophageal endoscopy was performed post-procedure to detect lesions, and cardiological follow-ups were conducted at 3, 12, and 24 months. Results: The cohort included 69% men, with a median age of 65.5 years. Post-ablation endoscopy was performed in 92 patients; esophageal lesions were found in 1.1% of Group A and none of Group B. GERD was diagnosed in 14% of patients, evenly distributed between groups and not linked to lesion occurrence. Gastric hypomotility was observed in 16% of patients, with no significant difference between groups. At 24 months, arrhythmia-free survival was 88% in Group A and 74% in Group B. Conclusion: Cryoballoon-assisted pulmonary vein isolation, with or without additional left atrial roof ablation and without esophageal temperature monitoring during a simplified sedation strategy, shows low risk of esophageal thermal injury and effective ablation outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Aortoesophageal Fistula Mimicking Dieulafoy Disease: A Case Report
- Author
-
Tatiana Pacheco, Pedro Costa-Moreira, Sara Monteiro, Joana Pinto, Luísa Barros, and Jorge Silva
- Subjects
esophageal fistula ,aortic diseases ,gastrointestinal bleeding ,computed tomography angiography ,aged 80 and over ,fístula esofágica ,doenças da aorta ,hemorragia gastrointestinal ,angiografia por tomografia computadorizada ,idosos, 80 anos ou mais ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introduction: Aortoesophageal fistula (AEF) is a rare and potentially fatal cause of upper gastrointestinal bleeding. The classic Chiari’s triad of symptoms and typical endoscopic findings are not present in all patients, making diagnosis challenging. Case Presentation: An 86-year-old man was admitted to the emergency room for melena and hematemesis with hemodynamic instability. He had a previous hospitalization for cardioembolic stroke complicated by hematemesis of unknown etiology after initiation of anticoagulation (which was suspended), being discharged on aspirin. His medical history also included hypertension, diabetes, ischemic heart disease, and prostate cancer. On upper endoscopy, no lesions were found, despite the presence of a large non-mobilizable clot in the gastric fundus. He was admitted to the intensive care unit, and, on the next day, reassessment esophagogastroduodenoscopy was normal. On the eighth day of hospitalization, the patient presented with hemorrhagic shock due to new-onset hematemesis. Upper endoscopy revealed an esophageal 10-mm non-ulcerated mucosal depression with a visible vessel at 20 cm from the incisors, closed with 3 hemoclips. Thoracic CT angiography showed a brachiocephalic trunk aneurysm with aortoesophageal fistulization. He was deemed unsuitable for endovascular or surgical treatment. About 2 months later, the patient was admitted to the emergency room in cardiorespiratory arrest following an episode of hematemesis at home. Discussion: This report highlights the diagnostic and therapeutic complexity of AEF. Endoscopic treatment can be the main therapy in patients without indication for vascular intervention. The purpose was to palliate new bleeding episodes, maintaining a very poor prognosis.
- Published
- 2024
- Full Text
- View/download PDF
12. Endoscopic Management of Esophageal Wall Defects
- Author
-
Mohammad Al-Haddad, Associate Professor of Medicine
- Published
- 2023
13. Esophageal and gastric pythiosis in a dog.
- Author
-
Sousa da Silva, Emanoelly Machado, Fernandes Martins, Kamila Peruchi, Barbosa Pereira, Asheley Henrique, Hentz Gris, Anderson, Harumi Maruyama, Fernanda, Nakazato, Luciano, Moleta Colodel, Edson, Schneider de Oliveira, Luiz Gustavo, and Marques Boabaid, Fabiana
- Subjects
- *
GASTROINTESTINAL system , *ESOPHAGEAL fistula , *DOGS , *DOG diseases , *GASTROINTESTINAL diseases , *GRANULATION tissue , *AUTOPSY - Abstract
Pythiosis is the disease caused by aquatic oomycetes of the genus Pythium. In dogs the typical course of the disease involves the gastrointestinal tract, characterized by transmural thickening of the stomach or intestines. However, infection by Pythium spp. has only rarely been recognized as a cause of esophagitis in dogs. Thus, the present reports a case of esophageal and gastric pythiosis in an eight-month-old female pit bull dog. The dog was attended at the hospital after two months presenting regurgitation and dyspnea. It was reported that the dog lived in an urban area and had no previous sanitary issues. At clinical examination it was noted that the dog presented crackling sounds at pulmonary auscultation. A support therapy accompanied by antibiotics has been employed; however, 22 days after hospitalization the clinical condition worsened, and the dog died. At necropsy, the wall of the distal segment of the esophagus and the cardia and part of the fundus of the stomach were expanded by a focal extensive irregular intramural annular mass. Additionally, there was a transmural esophageal fistula. At histology, the walls of the esophagus and stomach were extensively expanded by multifocal extensive areas of necrosis, associated with a pyogranulomatous infiltrate and abundant granulation tissue containing multiple negative images of hyphae that were highlighted by silver impregnation (Grocott). Furthermore, immunohistochemistry and PCR for P. insidiosum were both positive in samples of paraffin-embedded esophageal tissue. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Oesophago-pericardial fistula after catheter ablation of atrial fibrillation: a case report.
- Author
-
Wu, Shaohui, Zou, Guangchen, Sun, Yuzhang, Jiang, Weifeng, and Liu, Xu
- Subjects
CATHETER ablation ,ATRIAL fibrillation ,ESOPHAGEAL fistula ,FISTULA ,MEDICAL drainage ,CHEST pain ,COMPUTED tomography - Abstract
Background Oesophageal fistula is a rare complication of catheter ablation of atrial fibrillation with most fistulas being atrio-oesophageal fistulas, but oesophageal–pericardial fistula can also happen in the absence of atrial perforation. Case summary A 68-year-old male patient presented with chest pain 10 days after catheter ablation of paroxysmal atrial fibrillation. He was discharged after an initial negative workup that included a CT chest without contrast. He later presented again with severe chest pain and fever and was found to have an oesophageal–pericardial fistula. He underwent surgical and endoscopic treatment with good recovery. Discussion Patients with oesophago-pericardial fistulas often have delayed presentation 1–4 weeks after the ablation procedure. Early diagnosis can be challenging. CT with oral and intravenous contrast is often used for diagnosis. Treatment often includes antibiotics, surgical or interventional drainage of infected spaces with oesophageal repair, clipping or stenting. In contrast to atrio-oesophageal fistulas that carry a high mortality rate, mortality for oesophago-pericardial fistulas appears to be much lower. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Aortoesophageal fistula due to esophageal cancer: a case report of successful management.
- Author
-
Saisho, Kohei, Mori, Naoki, Nakagawa, Masashi, Nakamura, Eiji, Tanaka, Yu, Kaku, Hideaki, Tanaka, Yuya, Isobe, Taro, Otsuka, Hiroyuki, Sudo, Tomoya, Sakai, Hisamune, Ishibashi, Nobuya, Hisaka, Toru, Tayama, Eiki, and Fujita, Fumihiko
- Subjects
ESOPHAGEAL cancer ,ESOPHAGEAL fistula ,ENDOVASCULAR aneurysm repair ,THORACIC aorta ,ESOPHAGEAL tumors ,LOSS of consciousness - Abstract
Background: Aortoesophageal fistula (AEF) is a rare but potentially life-threatening condition. The best treatment for the AEF due to esophageal carcinoma is still unresolved. Here, we report a rare case of AEF caused by esophageal cancer, that was successfully treated with emergency thoracic endovascular aortic repair (TEVAR), followed by esophagectomy and gastric tube reconstruction. Case presentation: A 64-year-old man presented with loss of consciousness and hypotension during chemoradiotherapy for advanced esophageal cancer. Enhanced computed tomography showed extravasation from the descending aorta into the esophagus at the tumor site. We performed emergency TEVAR for the AEF, which stabilized the hemodynamics. We then performed thoracoscopic subtotal esophagectomy on day 4 after TEVAR to prevent graft infection, followed by gastric tube reconstruction on day 30 after TEVAR. At 9 months after the onset of AEF, the patient continues to receive outpatient chemotherapy and leads a normal daily life. Conclusion: TEVAR is a useful hemostatic procedure for AEF. If the patient is in good condition and can continue treatment for esophageal cancer, esophagectomy and reconstruction after TEVAR should be performed to prevent graft infection and maintain quality of life. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Prediction of malignant esophageal fistula in esophageal cancer using a radiomics-clinical nomogram.
- Author
-
Zhu, Chao, Sun, Wenju, Chen, Cunhai, Qiu, Qingtao, Wang, Shuai, Song, Yang, and Ma, Xuezhen
- Subjects
ESOPHAGEAL fistula ,NOMOGRAPHY (Mathematics) ,LOGISTIC regression analysis ,FEATURE extraction ,PANCREATIC fistula ,FEATURE selection ,ESOPHAGEAL cancer - Abstract
Background: Malignant esophageal fistula (MEF), which occurs in 5% to 15% of esophageal cancer (EC) patients, has a poor prognosis. Accurate identification of esophageal cancer patients at high risk of MEF is challenging. The goal of this study was to build and validate a model to predict the occurrence of esophageal fistula in EC patients. Methods: This study retrospectively enrolled 122 esophageal cancer patients treated by chemotherapy or chemoradiotherapy (53 with fistula, 69 without), and all patients were randomly assigned to a training (n = 86) and a validation (n = 36) cohort. Radiomic features were extracted from pre-treatment CTs, clinically predictors were identified by logistic regression analysis. Lasso regression model was used for feature selection, and radiomics signature building. Multivariable logistic regression analysis was used to develop the clinical nomogram, radiomics-clinical nomogram and radiomics prediction model. The models were validated and compared by discrimination, calibration, reclassification, and clinical benefit. Results: The radiomic signature consisting of ten selected features, was significantly associated with esophageal fistula (P = 0.001). Radiomics-clinical nomogram was created by two predictors including radiomics signature and stenosis, which was identified by logistic regression analysis. The model showed good discrimination with an AUC = 0.782 (95% CI 0.684–0.8796) in the training set and 0.867 (95% CI 0.7461–0.987) in the validation set, with an AIC = 101.1, and good calibration. When compared to the clinical prediction model, the radiomics-clinical nomogram improved NRI by 0.236 (95% CI 0.153, 0.614) and IDI by 0.125 (95% CI 0.040, 0.210), P = 0.004. Conclusion: We developed and validated the first radiomics-clinical nomogram for malignant esophageal fistula, which could assist clinicians in identifying patients at high risk of MEF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. A Successful Treatment of Broncho-Esophageal Fistula with Esophageal Stenting Using Direct Endoscopic Visualization.
- Author
-
Banciu, Christian, Aprotosoaie, Adrian, Vancea, Dorin, Taban, Sorina, Guse, Cristina, Budu, Oana, Fabian, Ramona, Chiriac, Sorin, Căruntu, Florina, and Voicu, Adrian
- Subjects
ESOPHAGEAL fistula ,TREATMENT effectiveness ,DATA visualization ,COMPUTED tomography ,PALLIATIVE treatment ,FISTULA ,BRONCHIAL fistula - Abstract
Broncho-esophageal fistula (BEF) is a severe yet relatively rare connection between the bronchus and esophagus usually caused by esophageal and pulmonary malignancies. We present a case report of a 49-year-old man diagnosed with terminal lung carcinoma who developed a BEF. The thoracic computed tomography scan detected a mass in the left bronchi that partially covers and disrupts the bronchial contour in certain regions and extends to the esophageal wall. After thoroughly evaluating alternative treatment approaches, we opt for the stenting procedure due to the advanced stage of the tumor and the significantly diminished quality of life. The treatment involves the use of a partially covered metal stent that is known to exhibit lower potential to migrate. The treatment is highly successful, resulting in a significant enhancement of the patient's quality of life, a lengthening in his survival, and the ability to pursue additional palliative treatment options. In contrast to the typical prosthesis implantation, our procedure uses a direct endoscopic visualization for the proximal deployment of a partially covered stent, offering a cost-effective and radiation-free alternative that can be particularly beneficial for BEF patients in facilities without radiology services. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Tracheoesophageal Fistula in a Tracheal Diverticulum Closed with Combined Esophagoscopy and Tracheoscopy: A Case Report.
- Author
-
Tong, Run, Lin, Jieru, Huang, Ke, Xu, Yingying, Liu, Fang, Deng, Mingming, Li, Jia, Zhou, Guowu, Du, Shiyu, and Hou, Gang
- Subjects
ELECTROCOAGULATION (Medicine) ,TRACHEAL fistula ,ESOPHAGEAL fistula ,PLATELET-rich plasma ,GLOW discharges ,ASPIRATION pneumonia ,ESOPHAGEAL atresia - Abstract
This article discusses a case report of a 26-year-old man who was admitted to the hospital with a history of recurrent cough and difficulty swallowing. The patient had a previous history of congenital esophageal atresia, which had been surgically corrected. Chest computed tomography revealed a tracheoesophageal fistula (TEF) within a tracheal diverticulum. The patient underwent two sessions of tracheoscopic treatment, but the fistula persisted. Four months later, a simultaneous tracheoscopy and esophagoscopy were performed to seal the fistula, and three months after the procedure, the closure of the fistula was confirmed. The article concludes that further studies are needed to assess the safety and efficacy of these multidisciplinary approaches for treating persistent TEFs. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
19. Azygos Vein Preservation; Its Impact on Early Outcomes After Neonatal EA/TOF Repair (EArAzygousvp)
- Author
-
dr. Muhammad Abdelhafez Mahmoud, MD, Lecturer of pediatric surgery, Al-Azhar Faculty of Medicine
- Published
- 2023
20. Oesophageal Protection Study: A Multicentre Study. (IMPACT II)
- Author
-
St. George's Hospital, London, University of Pennsylvania, National Health Service, United Kingdom, Berry Consultants, Virginia Commonwealth University, University of Colorado, Denver, Texas Cardiac Arrhythmia Research Foundation, Beth Israel Deaconess Medical Center, Royal Brompton & Harefield NHS Foundation Trust, The Queen Elizabeth Hospital, and Guy's and St Thomas' NHS Foundation Trust
- Published
- 2023
21. Outcome Predictors of Trachea-esophageal Fistula
- Author
-
Assem Abd El-razek Elkateeb, Doctor
- Published
- 2023
22. Vascular covered stent and video-assisted thoracoscopic surgery for Aortoesophageal fistula caused by esophageal fishbone: a case report.
- Author
-
Chen, Jianfeng
- Subjects
- *
VIDEO-assisted thoracic surgery , *ESOPHAGEAL fistula , *ENDOVASCULAR aneurysm repair , *THORACIC surgery , *AORTIC rupture , *THERAPEUTICS , *HOSPITAL admission & discharge - Abstract
Background: Aortoesophageal fistula (AEF) is a rare condition characterized by communication between the aorta and esophagus. AEF caused by an esophageal foreign body is even rare, and there is currently no recommended standard treatment protocol. We report a case of delayed aortic rupture after the endoscopic removal of a fish bone, which was successfully treated with a combined approach of vascular stenting and thoracic surgery. Case presentation: A 33-year-old man presented to the hospital after experiencing chest discomfort for 3 days following the accidental ingestion of a fish bone. Under endoscopic guidance, the fish bone was successfully removed, and the patient was subsequently admitted for medical therapy. On the fourth postoperative day, the patient suddenly developed hematemesis, and chest computed tomography angiography revealed the presence of an AEF. This necessitated urgent intervention; hence, thoracic surgery was performed and a vascular-covered stent was placed. Following the surgical procedure, the patient received active medical treatment, recovered well, and was successfully discharged from the hospital. Conclusions: In patients with esophageal perforation caused by foreign bodies, hospitalization for observation, computed tomography angiography examination, early use of antibiotics, and careful assessment of aortic damage are advised. Thoracic endovascular aortic repair and esophageal rupture repair may have benefits for the treatment of AEF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Primary cilia are critical for tracheoesophageal septation.
- Author
-
Fitzsimons, Lindsey Avery, Tasouri, Evangelia, Willaredt, Marc August, Stetson, Daniel, Gojak, Christian, Kirsch, Joachim, Gardner, Humphrey A. R., Gorgas, Karin, and Tucker, Kerry L.
- Subjects
CILIA & ciliary motion ,ESOPHAGEAL fistula ,HEDGEHOG signaling proteins ,HUMAN abnormalities ,CARRIER proteins - Abstract
Introduction: Primary cilia play pivotal roles in the patterning and morphogenesis of a wide variety of organs during mammalian development. Here we examined murine foregut septation in the cobblestone mutant, a hypomorphic allele of the gene encoding the intraflagellar transport protein IFT88, a protein essential for normal cilia function. Results: We reveal a crucial role for primary cilia in foregut division, since their dramatic decrease in cilia in both the foregut endoderm and mesenchyme of mutant embryos resulted in a proximal tracheoesophageal septation defects and in the formation of distal tracheo(broncho)esophageal fistulae similar to the most common congenital tracheoesophageal malformations in humans. Interestingly, the dorsoventral patterning determining the dorsal digestive and the ventral respiratory endoderm remained intact, whereas Hedgehog signaling was aberrantly activated. Conclusions: Our results demonstrate the cobblestone mutant to represent one of the very few mouse models that display both correct endodermal dorsoventral specification but defective compartmentalization of the proximal foregut. It stands exemplary for a tracheoesophageal ciliopathy, offering the possibility to elucidate the molecular mechanisms how primary cilia orchestrate the septation process. The plethora of malformations observed in the cobblestone embryo allow for a deeper insight into a putative link between primary cilia and human VATER/VACTERL syndromes. Key Findings: Identifies Ift88 as a gene responsible for trachea‐esophageal septation.Identifies primary cilia as essential for the trachea‐esophageal septation process.Proposes a novel mechanism for cilia‐dependent septation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Successful management of an atrio-esophageal fistula after atrial fibrillation ablation: a case report.
- Author
-
Hachiro, Kohei, Takashima, Noriyuki, Matsuoka, Kentaro, Takebayashi, Katsushi, Kaida, Sachiko, Tani, Masaji, and Suzuki, Tomoaki
- Subjects
- *
ESOPHAGEAL fistula , *ATRIAL fibrillation , *CATHETER ablation , *THORACOTOMY , *CARDIOPULMONARY bypass - Abstract
Background: Atrio-esophageal fistula is a rare but still a catastrophic complication of radiofrequency ablation of atrial fibrillation. We report a successful case of atrio-esophageal fistula with right posterolateral thoracotomy and right femoral cannulation of cardiopulmonary bypass. Case presentation: A 67-year-old man underwent radiofrequency ablation for atrial fibrillation. Nineteen days later, he developed cerebral infarction, and computed tomography showed air in the left atrium. He was transferred to our hospital for surgery. The upper body was placed in the left lateral decubitus position, and the lower body was placed in the left hemilateral decubitus position. The surgical approach was a right posterolateral thoracotomy in the 5th intercostal space. At first, the esophagus was transected at the diaphragm and tracheal carina levels. Then, an arterial line was inserted into the right common femoral artery and venous line into the right common femoral vein. Three U-shaped sutures of 3-0 polypropylene were placed to stop bleeding from the atrium. The esophagus was removed while snaring the 3-0 polypropylene sutures. There were two holes in the esophagus. Four drains were placed to clean the repaired site. After chest closure, the patient was placed supine. Cervical esophagostomy and enterostomy were performed. Gastric tube reconstruction via the retrosternal route was performed on postoperative day 28, and the patient was transferred to another hospital for rehabilitation on postoperative day 99. Conclusions: It is important to thoroughly discuss with esophageal surgeon how to reach the heart and esophagus, and how to reconstruct the esophagus later. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Novel Prediction Score for Arterial–Esophageal Fistula in Patients with Esophageal Cancer Bleeding: A Multicenter Study.
- Author
-
Lu, Sz-Wei, Niu, Kuang-Yu, Pai, Chu-Pin, Lin, Shih-Hua, Chen, Chen-Bin, Lo, Yu-Tai, Lee, Yi-Chih, Seak, Chen-June, and Yen, Chieh-Ching
- Subjects
- *
RESEARCH , *ESOPHAGEAL fistula , *SCIENTIFIC observation , *CONFIDENCE intervals , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *RESEARCH funding , *PREDICTION models , *LOGISTIC regression analysis , *ODDS ratio , *ESOPHAGEAL tumors , *HEMORRHAGE , *LONGITUDINAL method - Abstract
Simple Summary: In patients with esophageal cancer bleeding, the presence of tumor ulcer and arterial–esophageal fistula (AEF) is a common occurrence. Notably, AEF is associated with an exceptionally poor prognosis, yet there is no prediction score to estimate its occurrence rate. Therefore, we introduce a novel model, the HEARTS-Score, for predicting AEF in esophageal cancer bleeding patients. This predictive model effectively distinguishes patients at risk, as evidenced by a c-statistic of 0.82 (95% CI 0.72–0.92). By employing this model, clinicians can more objectively differentiate between high-risk and low-risk patients, facilitating more efficient clinical decision-making, diagnostic planning, and subsequent treatment strategies. Purpose: To develop and internally validate a novel prediction score to predict the occurrence of arterial–esophageal fistula (AEF) in esophageal cancer bleeding. Methods: This retrospective cohort study enrolled patients with esophageal cancer bleeding in the emergency department. The primary outcome was the diagnosis of AEF. The patients were randomly divided into a derivation group and a validation group. In the derivation stage, a predictive model was developed using logistic regression analysis. Subsequently, internal validation of the model was conducted in the validation cohort during the validation stage to assess its discrimination ability. Results: A total of 257 patients were enrolled in this study. All participants were randomized to a derivation cohort (n = 155) and a validation cohort (n = 102). AEF occurred in 22 patients (14.2%) in the derivation group and 14 patients (13.7%) in the validation group. A predictive model (HEARTS-Score) comprising five variables (hematemesis, active bleeding, serum creatinine level >1.2 mg/dL, prothrombin time >13 s, and previous stent implantation) was established. The HEARTS-Score demonstrated a high discriminative ability in both the derivation and validation cohorts, with c-statistics of 0.90 (95% CI 0.82–0.98) and 0.82 (95% CI 0.72–0.92), respectively. Conclusions: By employing this novel prediction score, clinicians can make more objective risk assessments, optimizing diagnostic strategies and tailoring treatment approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Fatal cerebral air embolism from atrio-oesophageal fistula following cardiac ablation.
- Author
-
Yann Shern Keh, Ryan, du Plessis, Daniel, Potter, Gillian M., Kobylecki, Christopher, and Cooper, Paul
- Subjects
- *
GASTROINTESTINAL hemorrhage , *CEREBRAL embolism & thrombosis , *DEATH , *HEADACHE , *BRAIN , *SUPRAVENTRICULAR tachycardia , *ESOPHAGEAL fistula , *CATHETER ablation , *GAS embolism - Abstract
A young woman with Rogers syndrome (thiamine-responsive megaloblastic anaemia, diabetes mellitus and sensorineural deafness) presented with headache, recurrent supraventricular tachycardia and features of an upper gastrointestinal bleed, 1 month after radiofrequency cardiac ablation for supraventricular tachycardia. She deteriorated rapidly after endoscopy and subsequently died. Brain imaging during the acute deterioration showed diffuse intracranial air embolism and hypoxic-ischaemic injury. Postmortem examination showed an atrio-oesophageal fistula, a rare complication of cardiac ablation. Clinicians should suspect this condition in patients with acute neurological deterioration after cardiac ablation who have diffuse air embolism on imaging. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Multi-omics and Multi-VOIs to predict esophageal fistula in esophageal cancer patients treated with radiotherapy.
- Author
-
Guo, Wei, Li, Bing, Xu, Wencai, Cheng, Chen, Qiu, Chengyu, Sam, Sai-kit, Zhang, Jiang, Teng, Xinzhi, Meng, Lingguang, Zheng, Xiaoli, Wang, Yuan, Lou, Zhaoyang, Mao, Ronghu, Lei, Hongchang, Zhang, Yuanpeng, Zhou, Ta, Li, Aijia, Cai, Jing, and Ge, Hong
- Abstract
Objective: This study aimed to develop a prediction model for esophageal fistula (EF) in esophageal cancer (EC) patients treated with intensity-modulated radiation therapy (IMRT), by integrating multi-omics features from multiple volumes of interest (VOIs). Methods: We retrospectively analyzed pretreatment planning computed tomographic (CT) images, three-dimensional dose distributions, and clinical factors of 287 EC patients. Nine groups of features from different combination of omics [Radiomics (R), Dosiomics (D), and RD (the combination of R and D)], and VOIs [esophagus (ESO), gross tumor volume (GTV), and EG (the combination of ESO and GTV)] were extracted and separately selected by unsupervised (analysis of variance (ANOVA) and Pearson correlation test) and supervised (Student T test) approaches. The final model performance was evaluated using five metrics: average area under the receiver-operator-characteristics curve (AUC), accuracy, precision, recall, and F1 score. Results: For multi-omics using RD features, the model performance in EG model shows: AUC, 0.817 ± 0.031; 95% CI 0.805, 0.825; p < 0.001, which is better than single VOI (ESO or GTV). Conclusion: Integrating multi-omics features from multi-VOIs enables better prediction of EF in EC patients treated with IMRT. The incorporation of dosiomics features can enhance the model performance of the prediction. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Pulsed‐field ablation does not induce esophageal and periesophageal injury—A new esophageal safety paradigm in catheter ablation of atrial fibrillation.
- Author
-
Grosse Meininghaus, Dirk, Freund, Robert, Koerber, Britta, Kleemann, Tobias, Matthes, Harald, and Geller, Johann Christoph
- Subjects
- *
ESOPHAGEAL injuries , *ESOPHAGEAL fistula , *ULTRASONIC imaging , *CONFIDENCE intervals , *ENDOSCOPIC surgery , *NERVOUS system , *VAGUS nerve , *CATHETER ablation , *ATRIAL fibrillation , *PARADIGMS (Social sciences) , *RESEARCH funding , *ENDOSCOPY , *LONGITUDINAL method - Abstract
Introduction: Esophageal injury is one of the most serious complications of pulmonary vein isolation (PVI) with thermic energy sources. Better tissue selectivity of primarily non‐thermic pulsed field ablation (PFA) may eliminate collateral injury, particularly the risk of atrio‐esophageal fistula (AEF). Objective: To compare the incidence of any (peri)‐esophageal injury following PVI using PFA to thermic energy sources. Methods: Using endoscopy, endoscopic ultrasound, and electrogastrography before and after PVI, esophageal and periesophageal injury (mucosal lesions, food retention, periesophageal edema, or vagal nerve injury) were assessed following PFA and radiofrequency (RF)‐ or cryoballoon (CB)‐PVI. Results: Between December 2022 and February 2023, 20 patients (67 ± 10 years, 53% male) undergoing PFA (Farapulse, Boston Scientific) for atrial fibrillation (AF) were studied and compared with a previous cohort of 57 patients who underwent thermic PVI (CB: n = 33; RF: n = 24). Following PFA‐PVI, none of the patients had mucosal lesions, food retention, or ablation‐induced vagal nerve injury; four patients showed periesophageal edema. Following thermic ablation, 33/57 patients (58%) showed esophageal and/or periesophageal injury (CB: 21/33 [64%], RF: 12/24 [50%]), in detail 4/57 mucosal lesions, 18/57 food retention, 17/57 vagal nerve injury, and 20/52 edema. Midterm success rates were similar for all energy sources. Conclusion: In contrast to thermic ablation tools, PFA is not associated with relevant esophageal and periesophageal injury, and might, therefore, reduce or eliminate the risk of potentially lethal AEF in interventional treatment of AF. The etiology of ablation‐induced periesophageal edema is unknown but has not been shown to be related to lesion progression. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Impact of pulsed field ablation on intraluminal esophageal temperature.
- Author
-
Kirstein, Bettina, Heeger, Christian‐H., Vogler, Julia, Eitel, Charlotte, Feher, Marcel, Phan, Huong‐Lan, Mushfiq, Ilias, Traub, Anna, Hatahet, Sascha, Samara, Omar, Subin, Behnam, Kuck, Karl‐Heinz, and Tilz, Roland R.
- Subjects
- *
ATRIAL fibrillation diagnosis , *TEMPERATURE , *ESOPHAGEAL fistula , *CATHETER ablation , *ATRIAL fibrillation , *TREATMENT effectiveness , *HEART beat , *PULMONARY veins - Abstract
Introduction: Atrio‐esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose‐dependent esophageal temperature rise has been reported. In the TESO‐PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated. Methods: Consecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA2DS2Vasc Score 2) underwent first‐time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12‐pole temperature probe. Results: Median TESO change was statistically significant and increased by 0.8 ± 0.6°C, p <.001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio‐esophageal fistula was reported on follow‐up. Conclusion: A small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. The important role of whole-process computed tomography guidance for percutaneous gastrostomy in esophageal cancer patients who are unsuitable for or have had unsuccessful attempts with endoscopic and fluoroscopic gastrostomy.
- Author
-
Geng, Xiang, Zhao, Qing, Yuan, Hang, Li, Hai-Liang, Guo, Chen-Yang, Yang, Ting, Fan, Wei-Jun, Park, Jung-Hoon, Zhao, Xiao-Hui, Zhu, Wen-Bo, and Hu, Hong-Tao
- Subjects
- *
ESOPHAGEAL cancer , *GASTROSTOMY , *COMPUTED tomography , *PERCUTANEOUS endoscopic gastrostomy , *ESOPHAGEAL fistula , *CANCER patients , *FLUOROSCOPY - Abstract
Purpose: To explore the value of clinical application with the whole process computed tomography (CT) guided percutaneous gastrostomy in esophageal tumor patients. Materials and methods: A consecutive series of 32 esophageal tumor patients in whom endoscopic gastrostomy or fluoroscopy guided gastrostomy were considered too dangerous or impossible due to the esophagus complete obstruction, complicate esophageal mediastinal fistula, esophageal trachea fistula or severe heart disease. All of the 32 patients were included in this study from 2 medical center and underwent the gastrostomy under whole process CT guided. Results: All of the gastrostomy procedure was finished successfully under whole process CT guided and the technical success rate was 100%. The average time for each operation was 27 min. No serious complications occurred and the minor complications occurred in 3 patients, including local infection, severe hyperplasia of granulation tissue and tube dislodgment. There were no procedure related deaths. Conclusion: The technical success rate of whole process CT guided percutaneous gastrostomy is high and the complication is low. This technique can be used feasible and effectively in some special patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Fecal calprotectin: A novel predictor of ulcerated esophageal injury after atrial fibrillation catheter ablation.
- Author
-
Wang, Yun‐He, Tang, Xiao‐Mei, Jiang, Ru‐Hong, Sun, Ya‐Xun, Liu, Qiang, Zhang, Pei, Yu, Lu, Lin, Jian‐Wei, Cheng, Hui, Chen, Shi‐Quan, Zhang, Zu‐Wen, Sheng, Xia, Lin, Ne, Chen, Xiao‐Li, Fu, Guo‐Sheng, and Jiang, Chen‐Yang
- Subjects
- *
ESOPHAGEAL injuries , *ANTIGEN analysis , *FECAL analysis , *ULCERS , *PREDICTIVE tests , *ESOPHAGEAL fistula , *INFLAMMATION , *RADIO frequency therapy , *ENDOSCOPIC ultrasonography , *ATRIAL fibrillation , *CATHETER ablation , *SURGICAL complications , *RISK assessment , *DESCRIPTIVE statistics , *ESOPHAGUS diseases , *RECEIVER operating characteristic curves , *SENSITIVITY & specificity (Statistics) , *PULMONARY veins , *LONGITUDINAL method , *DISEASE risk factors - Abstract
Background: Atrial esophageal fistula (AEF) is a lethal complication that can occur post atrial fibrillation (AF) ablation. Esophageal injury (EI) is likely to be the initial lesion leading to AEF. Endoscopic examination is the gold standard for a diagnosis of EI but extensive endoscopic screening is invasive and costly. This study was conducted to determine whether fecal calprotectin (Fcal), a marker of inflammation throughout the intestinal tract, may be associated with the existence of esophageal injury. Methods: This diagnostic study was conducted in a cohort of 166 patients with symptomatic AF undergoing radiofrequency catheter ablation from May 2020 to June 2021. Fcal tests were performed 1–7 days after ablation. All patients underwent endoscopic ultrasonography 1 or 2 days after ablation. Results: The levels of Fcal were significantly different between the EI and non‐EI groups (404.9 µg/g (IQR 129.6–723.6) vs. 40.4 µg/g (IQR 15.0–246.2), p <.001). Analysis of ROC curves revealed that a Fcal level of 125 µg/g might be the optimal cut‐off value for a diagnosis of EI, giving a 78.8% sensitivity and a 65.4% specificity. The negative predictive value of Fcal was 100% for ulcerated EI. Conclusions: The level of Fcal is associated with EI post AF catheter ablation. 125 µg/g might be the optimal cut‐off value for a diagnosis of EI. Negative Fcal could predict the absence of ulcerated EI, which could be considered a precursor to AEF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Perceptual Assessment of the Tracheoesophageal Voice
- Author
-
D'Alatri Lucia, Prof
- Published
- 2023
33. Use of Indocyanine Green During Primary Repair of Oesophageal Atresia and Distal Tracheo-oesophageal Fistula (iTOF)
- Published
- 2023
34. Platelet-rich plasma therapy for postoperative esophageal fistula in a pediatric patient.
- Author
-
Mitri, Marco Di, Chiastra, Greta, Collautti, Edoardo, D'Antonio, Simone, Buzzi, Marina, Bisanti, Cristian, Carmine, Annalisa Di, Catania, Vincenzo, Libri, Michele, Gargano, Tommaso, and Lima, Mario
- Subjects
- *
ESOPHAGEAL fistula , *CHILD patients , *PLATELET-rich plasma , *CORD blood , *UMBILICAL cord clamping , *POSTOPERATIVE care ,ESOPHAGEAL atresia - Abstract
Postoperative management of esophagocutaneous fistulas in pediatric patients is challenging, often resulting in prolonged hospitalization and increased morbidity. Platelet-rich plasma (PRP) has emerged as a promising adjunctive treatment for such complications. We present the case of a 7-month-old infant who developed an esophago-cutaneous fistula following esophagocoloplasty for esophageal atresia type A. Despite initial conservative management, the fistula persisted, prompting the application of PRP gel derived from umbilical cord blood. After four applications of PRP, complete closure of the fistula was achieved, leading to both functional and aesthetic results. This case highlights the potential of PRP in managing refractory postoperative esophageal fistulas in pediatric patients and underscores the need for further research to optimize treatment protocols and validate its efficacy for this sort of complications [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. A Rare Cause of Upper Gastrointestinal Bleeding: Aorta-Esophageal Fistula.
- Author
-
Ölmez, Şehmus, Cereb, Ferid, Çelikdemir, Ayşe Yıldırım, Çapar, Halil, Çetin, Duran Deha, and Sarıtaş, Bünyamin
- Subjects
GASTROINTESTINAL hemorrhage ,ESOPHAGEAL fistula ,AORTIC aneurysms ,TREATMENT effectiveness ,THORACIC surgery - Abstract
Aortoesophageal fistula (AEF) is rarely seen in gastroenterology practice. It is a very fatal condition. Common causes of AEF are aortic aneurysms and dissections, foreign body ingestion, traumatic aortic injuries, ruptured penetrating aortic ulcers, esophageal or bronchogenic malignancies, and thoracic surgery such as thoracic endovascular aortic repair (TEVAR). Post-TEVAR AEF is a very rare cause of massive upper gastrointestinal bleeding (UGIB). Management of AEF is difficult and causes serious outcomes. Here we report a case presented with UGIB related to post-TEVAR AEF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Self-expandable metallic stent-induced esophagorespiratory fistulas in patients with advanced esophageal cancer
- Author
-
Iatagan R. Josino, Bruno C. Martins, Andressa A. Machado, Gustavo R. de A. Lima, Martin A. C. Cordero, Amanda A. M. Pombo, Rubens A. A. Sallum, Ulysses Ribeiro Jr, Todd H. Baron, and Fauze Maluf-Filho
- Subjects
esophageal fistula ,esophageal neoplasms ,self-expandable metallic stents ,Internal medicine ,RC31-1245 ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background/Aims Self-expandable metallic stents (SEMSs) are widely adopted for the palliation of dysphagia in patients with malignant esophageal strictures. An important adverse event is the development of SEMS-induced esophagorespiratory fistulas (SEMS-ERFs). This study aimed to assess the risk factors related to the development of SEMS-ERF after SEMS placement in patients with esophageal cancer. Methods This retrospective study was performed at the Instituto do Cancer do Estado de São Paulo. All patients with malignant esophageal strictures who underwent esophageal SEMS placement between 2009 and 2019 were included in the study. Results Of the 335 patients, 37 (11.0%) developed SEMS-ERF, with a median time of 129 days after SEMS placement. Stent flare of 28 mm (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.15–5.51; p=0.02) and post-stent chemotherapy (HR, 2.0; 95% CI, 1.01–4.00; p=0.05) were associated with an increased risk of developing SEMS-ERF, while lower-third tumors were a protective factor (HR, 0.5; 95% CI, 0.26–0.85; p=0.01). No difference was observed in overall survival. Conclusions The incidence of SEMS-ERFs was 11%, with a median time of 129 days after SEMS placement. Post-stent chemotherapy and a 28 mm stent flare were associated with a higher risk of SEMS-ERF.
- Published
- 2023
- Full Text
- View/download PDF
37. Refractory esophageal–mediastinal fistula successfully treated with endoluminal vacuum therapy and enteral nutrition using a double-lumen elemental diet tube: a case report.
- Author
-
Yoshidome, Shizuka, Sasaki, Ken, Fumoto, Hideyuki, Tsuruda, Yusuke, Shimonosono, Masataka, Uchikado, Yasuto, Matsushita, Daisuke, Arigami, Takaaki, Baba, Kenji, Kurahara, Hiroshi, and Ohtsuka, Takao
- Subjects
- *
ESOPHAGEAL fistula , *ENDOVASCULAR aneurysm repair , *ENTERAL feeding , *DISEASES in men , *HOSPITAL care - Abstract
Background: Aortic–esophageal fistula (AEF) after thoracic endovascular aortic repair (TEVAR) has a high fatality rate and is difficult to treat. Endoluminal vacuum therapy (EVT) has recently appeared and proven to be a useful method for anastomotic leakage. Case presentation: A 76-year-old man underwent aortic arch replacement for a stent graft infection after TEVAR. Persistent mediastinitis and pyothorax were observed after aortic arch replacement, and further examination revealed an esophageal–mediastinal fistula (EMF). Over-the-scope clip (OTSC®) closure was performed to treat EMF but achieved no cure. Then, the patient was referred to our hospital. First, we removed the OTSC® that interfered with the treatment using the remOVE System® and started EVT using a double-lumen elemental diet tube (W–EDT®). The vacuum sponge was affixed to the vacuum side of W–EDT®, and enteral nutrition administered through W–EDT was combined with EVT. EMF was cured 11 days after EVT, and the patient was able to feed himself. Conclusion: The combination of EVT and enteral nutrition feeding using W–EDT® is a successful novel procedure to treat refractory EMF. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
38. Self-expandable metallic stent-induced esophagorespiratory fistulas in patients with advanced esophageal cancer.
- Author
-
Josino, Iatagan R., Martins, Bruno C., Machado, Andressa A., de A. Lima, Gustavo R., Cordero, Martin A. C., Pombo, Amanda A. M., Sallum, Rubens A. A., Ribeiro Jr, Ulysses, Baron, Todd H., and Maluf-Filho, Fauze
- Subjects
- *
CANCER patients , *ESOPHAGEAL cancer , *FISTULA , *ESOPHAGEAL fistula , *OVERALL survival , *CONFIDENCE intervals - Abstract
Background/Aims: Self-expandable metallic stents (SEMSs) are widely adopted for the palliation of dysphagia in patients with malignant esophageal strictures. An important adverse event is the development of SEMS-induced esophagorespiratory fistulas (SEMSERFs). This study aimed to assess the risk factors related to the development of SEMS-ERF after SEMS placement in patients with esophageal cancer. Methods: This retrospective study was performed at the Instituto do Cancer do Estado de São Paulo. All patients with malignant esophageal strictures who underwent esophageal SEMS placement between 2009 and 2019 were included in the study. Results: Of the 335 patients, 37 (11.0%) developed SEMS-ERF, with a median time of 129 days after SEMS placement. Stent flare of 28 mm (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.15-5.51; p=0.02) and post-stent chemotherapy (HR, 2.0; 95% CI, 1.01-4.00; p=0.05) were associated with an increased risk of developing SEMS-ERF, while lower-third tumors were a protective factor (HR, 0.5; 95% CI, 0.26-0.85; p=0.01). No difference was observed in overall survival. Conclusions: The incidence of SEMS-ERFs was 11%, with a median time of 129 days after SEMS placement. Post-stent chemotherapy and a 28 mm stent flare were associated with a higher risk of SEMS-ERF. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
39. Management and Outcomes of Esophageal Atresia With or Without Tracheo-Esophageal Fistula Over 15 Years in South Africa.
- Author
-
Odera, Agneta, Peer, Nasheeta, Balakrishna, Yusentha, and Sheik Gafoor, Mahomed Hoosen
- Subjects
- *
ESOPHAGEAL fistula , *POOR communities , *BIRTH weight , *FISTULA , *NEONATOLOGY , *NEONATAL surgery ,ESOPHAGEAL atresia - Abstract
To determine the incidence, management and outcomes of esophageal atresia/tracheo-esophageal fistula (EA/TEF) over a 15-y period in South Africa. A retrospective chart review of neonates with EA/TEF presenting at the main tertiary referral hospital in the KwaZulu-Natal province between 2002 and 2017 was conducted. Data collection comprised patient and maternal demographics, clinical presentations, laboratory and radiologic investigations, surgical procedures, and outcomes. A multivariate logistic regression determined the risk factors associated with mortality. Among 180 neonates, mean (SD) age of diagnosis was four (three) days postnatal with Gross Type C (n = 165, 92%) being the most common and the incidence was one per 10,000 live births. Majority were born term (n = 95, 53%) at peripheral hospitals (n = 167, 93%) with a mean birth weight of 2369 (736) grams. Overall HIV exposure rate was 27% (n = 48). Most (n = 138, 77%) patients presented with established pneumonia, 44% (n = 61) of whom required prolonged (>7 d) ventilator support. The median (IQR) hospital stay was 11 (8-20) d. Overall survival rate was 70% (n = 126). Birth weight <1500 g, life threatening anomalies, ventilation >30 d and postoperative sepsis contributed to mortality. Incidence, disease types and presentations were similar to developed countries. Despite advances in technology and neonatal care in Africa, EA/TEF surgical outcomes remain suboptimal likely due to caregivers' inability to care for these infants in disadvantaged socioeconomic circumstances with poor sanitation, etc. Research is needed to identify strategies tailored for disadvantaged communities which may contribute to improved outcomes in the perioperative and postoperative period. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
40. Impact of radiotherapy on adverse events of self-expanding metallic stents in patients with esophageal cancer.
- Author
-
Machado, Andressa A, Martins, Bruno C, Josino, Iatagan R, Chen, André T C, Hong, Carlos B C, Santos, Alisson L D R, Lima, Gustavo R A, Cordero, Martin A C, Safatle-Ribeiro, Adriana V, Pennacchi, Caterina, Gusmon, Carla C, Paulo, Gustavo A, Lenz, Luciano, Lima, Marcelo S, Baba, Elisa R, Kawaguti, Fábio S, Uemura, Ricardo S, Sallum, Rubens A A, Jr, Ulysses Ribeiro, and Maluf-Filho, Fauze
- Subjects
- *
CANCER patients , *ESOPHAGEAL fistula , *ESOPHAGEAL tumors , *CHEST pain , *GASTROESOPHAGEAL reflux , *RADIOTHERAPY , *ESOPHAGEAL cancer - Abstract
Self-expanding metallic stents (SEMS) are considered the treatment of choice for the palliation of dysphagia and fistulas in inoperable esophageal neoplasms. However, the safety of SEMSs in patients who received or who will be submitted to radiotherapy (RT) is uncertain. The study aimed to evaluate the impact of RT on adverse events (AEs) in patients with esophageal cancer with SEMSs. This is a retrospective study conducted at a tertiary cancer hospital from 2009 to 2018. We collected information regarding RT, the histological type of the tumor, the model of SEMSs and AEs after stent placement. Three hundred twenty-three patients with malignant stenosis or fistula were treated with SEMSs. The predominant histological type was squamous cell carcinoma (79.6%). A total of 282 partially covered and 41 fully covered SEMSs were inserted. Of the 323 patients, 182 did not received RT, 118 received RT before SEMS placement and 23 after. Comparing the group that received RT before stent insertion with the group that did not, the first one presented a higher frequency of severe pain (9/118 7.6% vs. 3/182 1.6%; P = 0.02). The group treated with RT after stent placement had a higher risk of global AEs (13/23 56.5% vs. 63/182 34.6%; P = 0.019), ingrowth/overgrowth (6/23 26.1% vs. 21/182 11.5%; P = 0.045) and gastroesophageal reflux (2/23 8.7% vs. 2/182 1.1%; P = 0.034). Treatment with RT before stent placement in patients with inoperable esophageal neoplasm prolongs survival and is associated with an increased risk of severe chest pain. Treatment with RT of patients with an esophageal stent increases the frequency of minor, not life-threatening AEs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
41. Removal of the Evolution® Esophageal Stent - Fully Covered (CLARITY)
- Published
- 2022
42. Inverse Ratio Ventilation in Neonatal Open Repair of Tracheoesophageal Fistula.
- Author
-
Akram Mohamed Mohamed Amer, Lecturer in the department of Anesthesia
- Published
- 2022
43. Chronic esophageal fistula as a rare cause of secondary osteomyelitis of the thoracic spine
- Author
-
Valeriya A. Zarya, Pavel V. Gavrilov, Marina E. Makogonova, Andrey R. Kozak, and Arkadiy A. Vishnevskiy
- Subjects
osteomyelitis ,spondylitis ,esophageal fistula ,Computer applications to medicine. Medical informatics ,R858-859.7 - Abstract
Infectious diseases affecting the spine are inflammatory destructive diseases that involved the organ and its structural elements as a result of infection by hematogenic, lymphogenic, or contact pathways, including may be a complication of surgical intervention. In arriving at an accurate diagnosis, it is extremely important to evaluate the anamnesis, the clinical picture, as well as the data of laboratory studies and radiation diagnostics in the aggregate. This article presents a clinical case with the development of secondary ThVII–ThVIII vertebral spondylitis due to esophageal fistula. At the initial diagnosis, spondylitis was associated with spinal anesthesia performed six months prior to onset of the disease, as there was a fistulous defect on the skin in the lumbar region. Consequently, surgical interventions were performed three times in a surgical hospital at the place of residence. The data from the endoscopic examination, as well as the patient’s complaints regarding the relationship between meals, the appearance of pain, and the nature of the discharge from the fistula were not taken into account by doctors initially. With the help of an additional examination, including computed tomography of the esophagus with oral contrast and computed tomography fistulography, the main diagnosis was esophageal fistula. Thoracic spondylitis was only a secondary complication. Thus, the final diagnosis of back pain and fistula in the lumbar region should be formulated after differential diagnosis with alternative diseases of the spine.
- Published
- 2023
- Full Text
- View/download PDF
44. Have the cake and eat it too: PFA, a case of a technological miracle?
- Author
-
Avitall, Boaz
- Subjects
- *
ESOPHAGUS , *ESOPHAGEAL fistula , *SERIAL publications , *RADIO frequency therapy , *CATHETER ablation , *ATRIAL fibrillation , *MEDICAL technology , *ELECTROPHYSIOLOGY , *ABLATION techniques - Abstract
An introduction is presented in which the editor discusses articles in the issue on topics including Farapulse Pulse Field Ablation (PFA) System Thermal and Pathological Changes, Esophageal Temperature Changes Recorded by Circa Scientific Probe (Kirstein et al.), and other related subjects.
- Published
- 2024
- Full Text
- View/download PDF
45. PrOgnosis Following Esophageal fisTula formaTion in Pts Undergoing cathetER Ablation for AF Study (POTTER)
- Author
-
Dr.Ahmad Keelani and Prof. Roland Richard Tilz, Prof. Dr. med. Roland Richard Tilz
- Published
- 2022
46. Swallowing, Feeding and Eating in Children Born With Oesophageal Atresia/Trache-oesophageal Fistula (OA/TOF) (SaFE)
- Author
-
National Institute for Health Research, United Kingdom
- Published
- 2022
47. Open or Keyhole Surgery Through the Chest for Newborn Babies: Effect on Blood Gases (CO2)
- Published
- 2022
48. Conservative endoscopic closure with fibrin glue of an aorto-esophageal fistula secondary to endovascular repair of a contained penetrating atherosclerotic ulcer rupture
- Author
-
Nancy Halloum, MD, Mahmoud Abdalhafez, MD, Florian Thieringer, MD, Daniel Grimm, MD, Hendrik Treede, MD, PhD, and Hazem El Beyrouti, MD, PhD
- Subjects
Aorta ,Aortic ulcer ,Endoscopy ,Endovascular procedures ,Esophageal fistula ,Esophagus vacuum therapy ,Surgery ,RD1-811 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
An aorto-esophageal fistula (AEF) is a rare complication of aortic surgery but can cause potentially lethal upper gastrointestinal tract bleeding. A patient presented with an AEF secondary to emergency endovascular repair of a contained penetrating atherosclerotic ulcer rupture of the thoracic aorta and was successfully treated with endoscopic closure using fibrin glue. As endovascular repair becomes increasingly common, a greater incidence of AEFs should be anticipated and the treatment options better described.
- Published
- 2023
- Full Text
- View/download PDF
49. Retrospective analysis of 10 cases with esophageal fistula after anterior surgery for cervical spine fracture
- Author
-
Jinpeng Du, Xiangcheng Gao, Dingjun Hao, Zhengxue Quan, Liang Yan, and Baorong He
- Subjects
Anterior surgery ,Complication ,Esophageal fistula ,Spine fracture ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Objective: This study aims to discuss the appropriate treatment of esophageal fistula following anterior surgery for cervical spine fracture. Methods: Clinical data of patients with cervical spine fracture treated at our research center from January 2000 to December 2019 were screened. Data of patients with esophageal fistula were included, and the causes of injury, diagnosis, and treatment were retrospectively analyzed. Results: A total of 3578 patients with cervical spine fracture were screened, among whom there were 10 cases (0.28 %) of esophageal fistula. 60 % of the cases were early-onset and all were caused by intraoperative electric knife injury. The positive rate of early endoscopy was only 25 %, while routine radiography showed a positive rate of 33.3 % after three attempts. Among the six patients with early-onset esophageal fistula, three underwent sternocleidomastoid flap transfer and two underwent primary suture, all achieving successful healing. In the four cases of late-onset esophageal fistula, two patients received implant removal, debridement, incision lavage, and sternocleidomastoid muscle flap transfer three weeks later. One patient received implant removal, debridement, vacuum sealing drainage, followed by sternocleidomastoid muscle pedicle transfer muscle flap plus lavage two weeks later and achieved complete recovery. All patients gargled alternately with metronidazole and chlorhexidine gargle after surgery. Conclusion: The occurrence of esophageal fistula is associated with surgical procedures, esophageal injury, and implant compression. Esophagography and endoscopy are the primary diagnostic methods, while incision exploration after ingestion of food mixed with methylene serves as a supplementary approach. Recommended treatments include alternating metronidazole and chlorhexidine gargles, esophageal rest, repair of the fistula, muscle flap packing, lavage and drainage, nutritional support, and removal of internal fixation if necessary. Post-surgery administration of antibiotics should continue until three consecutive lavage cultures yield negative results.
- Published
- 2023
- Full Text
- View/download PDF
50. Efficacy and Safety of Self-Expandable Metallic Stent Placement for Malignant Esophageal Fistula.
- Author
-
Izumi, Atsuko, Yoshio, Toshiyuki, Sasaki, Takashi, Ishioka, Mitsuaki, Kizawa, Atsuko, Ikenoyama, Yohei, Namikawa, Ken, Tokai, Yoshitaka, Yoshimizu, Shoichi, Horiuchi, Yusuke, Ishiyama, Akiyoshi, Hirasawa, Toshiaki, Chin, Keisho, Ogura, Mariko, Sasahira, Naoki, and Fujisaki, Junko
- Subjects
- *
ESOPHAGEAL fistula , *PALLIATIVE treatment , *SURVIVAL rate , *CANCER hospitals , *ESOPHAGEAL cancer , *FISTULA , *BRONCHIAL fistula , *CHEMORADIOTHERAPY - Abstract
Patients with malignant esophageal fistulas often experience dysphagia and infection, resulting in poor prognoses. Self-expandable metallic stent (SEMS) placement is a palliative treatment option; however, its efficacy and safety are unclear. We aimed to determine the efficacy and safety of SEMS placement for malignant esophageal fistulas. We retrospectively investigated patients who underwent SEMS placement for malignant esophageal fistulas between 2013 and 2022 at the Cancer Institute Hospital. Dysphagia scores (DSs) before and after SEMS placement, adverse events, and overall survival from SEMS placement until death were evaluated. A total of 17 patients underwent SEMS placement, including 12 and 5 patients with esophageal and lung cancers, respectively. Prior treatments included chemoradiotherapy (n = 11), radiotherapy (n = 4), and chemotherapy (n = 4); two patients underwent palliative radiotherapy after chemotherapy. All procedures were technically successful. After SEMS placement, 14 (82.4%) patients were able to consume semisolid or solid food (DS ≤ 2). Major adverse events were encountered in only one case. The median survival time after SEMS placement was 71 days (range 17–247 days). SEMS placement allowed most patients to resume oral intake with a low rate of major adverse events. SEMS placement is a reasonable palliative treatment option for patients with malignant fistulas who have poor prognoses. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.